5
项与 13价肺炎球菌结合疫苗(多价结合体)(成都安特金生物技术) 相关的临床试验13价肺炎球菌结合疫苗(多价结合体)III 期(2-3 月龄)临床试验的免疫持久性补充临床试验
评价2月龄(最小满6 周龄)和3月龄婴幼儿完成基础免疫3剂和加强免疫1剂13价肺炎球菌结合疫苗接种后的免疫持久性。
Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants Aged 2 Months (at Least 6 Weeks) and 3 Months
This study is a phase III clinical trial to evaluate the immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine (multivalent conjugate) in infants aged 2 months (at least 6 weeks) and 3 months. The main objectives of the study include: 1. To evaluate the immunogenicity of the trial vaccine in infants aged 2 months (at least 6 weeks) following the corresponding immunization schedule compared to the control vaccine; 2. To evaluate the immunogenicity of the trial vaccine in infants aged 3 months following the corresponding immunization schedule compared to the 2-month group; 3. To evaluate the safety of the trial vaccine in infants aged 2 months (at least 6 weeks) and 3 months following the corresponding immunization schedule.
评价13价肺炎球菌结合疫苗(多价结合体)在2月龄(最小满6周龄)和3月龄婴幼儿中的免疫原性和安全性的III期临床试验
1、与对照苗比较,评价试验疫苗在2月龄(最小满6周龄)和3月龄婴幼儿中按照相应免疫程序接种后的免疫原性;
2、评价试验疫苗在2月龄(最小满6周龄)和3月龄人群中接种后的安全性。
100 项与 13价肺炎球菌结合疫苗(多价结合体)(成都安特金生物技术) 相关的临床结果
100 项与 13价肺炎球菌结合疫苗(多价结合体)(成都安特金生物技术) 相关的转化医学
100 项与 13价肺炎球菌结合疫苗(多价结合体)(成都安特金生物技术) 相关的专利(医药)
100 项与 13价肺炎球菌结合疫苗(多价结合体)(成都安特金生物技术) 相关的药物交易